Philippines says new mpox case 'not' deadly variant

HEADLINES:
|

ADVERTISEMENT

HEADLINES:
|

Philippines says new mpox case 'not' deadly variant

Agence France-Presse

Clipboard

Colorized transmission electron micrograph of mpox virus particles (teal) found within an infected cell (brown), cultured in the laboratory. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID Colorized transmission electron micrograph of mpox virus particles (teal) found within an infected cell (brown), cultured in the laboratory. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID 

The first mpox case reported by the Philippines this year is a mild variant and not the deadly strain sparking global alarm, Health Secretary Teodoro Herbosa said Wednesday.

The highly transmissible Clade 1b strain of the virus has killed hundreds of people in the Democratic Republic of Congo and has also been detected Burundi, Kenya, Rwanda, Uganda and Sweden.

"It's the old variant," Herbosa said of the virus that struck a 33-year-old Filipino male, referring to the mild Clade 2 variant.

"It's not as alarming as the Clade 1b," Herbosa told AFP.

ADVERTISEMENT

He said the patient had not travelled outside the country and was "still confined" in the hospital.

"For us doctors, that means the virus is circulating in the community," Herbosa said.

Nine mpox cases were reported by Philippine authorities in 2022 and 2023, with the previous most recent one last December.

President Ferdinand Marcos on Tuesday ordered health officials to continuously monitor areas and people vulnerable to the virus.

© Agence France-Presse


ADVERTISEMENT

ADVERTISEMENT

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

It looks like you’re using an ad blocker

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker on our website.

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker on our website.